This company listing is no longer active
Resumen de acción 2HJ
Brighter AB (publ), a health-tech company, develops solutions for the treatment of chronic condition in Sweden and internationally.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Recompensas
Análisis de riesgos
+ 2 riesgos adicionales
Competidores de Brighter AB (publ)
Historial de precios y rendimiento
Historical stock prices | |
---|---|
Current Share Price | €0.0001 |
52 Week High | €0.042 |
52 Week Low | €0.0001 |
Beta | 1.62 |
1 Month Change | 0% |
3 Month Change | 0% |
1 Year Change | -99.76% |
3 Year Change | -99.99% |
5 Year Change | n/a |
Change since IPO | -99.99% |
Noticias y actualizaciones recientes
Recent updates
Rentabilidad de los accionistas
2HJ | DE Medical Equipment | Mercado DE | |
---|---|---|---|
7D | 0% | -1.9% | -1.0% |
1Y | -99.8% | -10.8% | 2.0% |
Rentabilidad vs. Industria: 2HJ underperformed the German Medical Equipment industry which returned -20.7% over the past year.
Rentabilidad vs. Mercado: 2HJ underperformed the German Market which returned -16.6% over the past year.
Volatilidad de los precios
2HJ volatility | |
---|---|
2HJ Average Weekly Movement | 1,761.6% |
Medical Equipment Industry Average Movement | 4.6% |
Market Average Movement | 4.9% |
10% most volatile stocks in DE Market | 10.3% |
10% least volatile stocks in DE Market | 2.4% |
Precio estable de las acciones: 2HJ's share price has been volatile over the past 3 months.
Volatilidad a lo largo del tiempo: 2HJ's weekly volatility has increased from 887% to 1762% over the past year.
Acerca de la empresa
Fundada | Empleados | CEO | Página web |
---|---|---|---|
2007 | 57 | Erik Lissner | brighter.se |
Resumen de fundamentos de Brighter AB (publ)
Estadísticas fundamentales de 2HJ | |
---|---|
Capitalización bursátil | €14.76m |
Beneficios(TTM) | -€16.94m |
Ingresos (TTM) | €3.05m |
0.0x
Ratio precio-ventas (PS)0.0x
Ratio precio-beneficio (PE)¿Está 2HJ sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
Cuenta de resultados (TTM) de 2HJ | |
---|---|
Ingresos | kr33.03m |
Coste de los ingresos | kr10.88m |
Beneficio bruto | kr22.15m |
Otros gastos | kr205.85m |
Beneficios | -kr183.70m |
Últimos beneficios comunicados
Jun 30, 2022
Próxima fecha de beneficios
Nov 29, 2022
Beneficios por acción (BPA) | -0.21 |
Margen bruto | 67.05% |
Margen de beneficio neto | -556.20% |
Ratio deuda/patrimonio | 1.7% |
¿Cómo se ha desempeñado 2HJ a largo plazo?
Ver rendimiento histórico y comparativa